The approval covers a six-month sustained-release version of Decapeptyl®, an LHRH agonist. Debiopharm and its European marketing partner, Ipsen, confirmed regulatory approval of its prostate cancer ...

This article may contain links from our affiliate and advertising partners. We may receive payments when you click on links, buy through them or share this content. I did my first round of IVF back in ...